News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|October 25, 2017

Why Look for Molecular Markers?

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

BySpencer Feldman

December 12th 2025

image of woman.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025

mobile phone

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

December 12th 2025

Trending on CURE

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

What Does Minimal Residual Disease Mean?

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

© 2025 MJH Life Sciences^®

All rights reserved.